Save the date – Episurf Medical capital markets day 2022

Episurf Medical (Nasdaq: EPIS B) invites investors, analysts, and media to a capital markets day on Wednesday 16 November 2022.

Presentations will be held by members of Episurf Medical’s management group, focusing on the company’s global commercial opportunities and strategy for the coming years.

“We are clearly entering into a new phase with an increased focus on commercial opportunities. Following several years with a focus on product development and clinical studies, we look forward to providing investors and other interested parties with an update about the next steps”, says Pål Ryfors, CEO Episurf Medical.

The capital markets day on 16 November 2022 starts at 13:00 CET and ends at 16:00 CET. The event will take place in central Stockholm, Sweden, and a link (live) to the event and the complete programme will be available on www.episurf.com before the event. A webcast of the event will also be available after the event on the company’s website.

Welcome!

For more information, please contact:

Pål Ryfors, CEO, Episurf Medical
Tel:+46 (0) 709 62 36 69
Email: pal.ryfors@episurf.com

Veronica Wallin, CFO, Episurf Medical
Tel:+46 (0) 700 37 48 95
Email: veronica.wallin@episurf.com

About Episurf Medical

Episurf Medical is endeavoring to bring people with painful joint injuries a more active, healthier life through the availability of minimally invasive and individualised treatment alternatives. Episurf Medical’s Episealer® individualised implants and Epiguide® surgical drill guides are developed for treating localised cartilage injury in joints. Episurf Medical’s μiFidelity® system enables implants to be cost-efficiently tailored to each individual’s unique injury for the optimal fit and minimal intervention. Episurf Medical’s head office is in Stockholm, Sweden. Its share (EPIS B) is listed on Nasdaq Stockholm. For more information, go to the company’s website: www.episurf.com.